article thumbnail

Rivus raises $132m to advance clinical development of obesity treatment

Pharmaceutical Technology

Rivus Pharmaceuticals has raised $132m in a Series B funding round to clinically advance its lead candidate, HU6, for the treatment of obesity and cardio-metabolic disorders.

article thumbnail

Insilico Medicine appoints Sujata Rao, M.D., as Senior Vice President to oversee clinical development

Scienmag

Social & Behavioral Science appoints clinical development Insilico M.D

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Future of clinical development highlighted in online event

Outsourcing Pharma

Experts from the Decentralized Trials and Research Alliance and Rafael Pharmaceuticals discuss progress and possibilities during Clinical Development Advances. Clinical Development

article thumbnail

Navigating the challenges of proper fill and finish in clinical development

Bio Pharma Dive

Given all the uncertainties of fill and finish in clinical development, one thing is certain – there is little room for failure, and rarely a second chance

article thumbnail

Acute lymphocytic leukaemia leads in cell therapy clinical development

Pharmaceutical Technology

The post Acute lymphocytic leukaemia leads in cell therapy clinical development appeared first on Pharmaceutical Technology.

article thumbnail

Ukraine war dramatically impacting global clinical development: Phesi

Outsourcing Pharma

The companyâs analysis of clinical research activity in the region shows the conflict will have long-lasting effects that reach beyond the countryâs borders. Clinical Development

article thumbnail

Vaderis exits stealth as ex-Almac Discovery candidate enters clinical development

Outsourcing Pharma

The clinical-stage biotechnology company is working on the advancement of a treatment for a blood vessel disorder that it licensed from the other company. Clinical Development

article thumbnail

Nimbus Therapeutics Strengthens Clinical Development Leadership Team

BioTech 365

Nimbus Therapeutics Strengthens Clinical Development Leadership Team Nimbus Therapeutics Strengthens Clinical Development Leadership Team CAMBRIDGE, Mass.–(BUSINESS

article thumbnail

Samsung Biologics to help Enzolytics advance clinical development of mAbs

BioPharma Reporter

Samsung Biologics and Enzolytics have entered into a strategic CDMO partnership agreement targeting monoclonal antibody production. Upstream Processing

Antibody 114
article thumbnail

Adverum Down After Clinical Development Shift for Gene Therapy Program

BioSpace

Shares of Adverum Biotechnologies plunged more than 20% in premarket trading after the company announced it was revising its clinical development plan for investigational gene therapy candidate ADVM-022 based on safety concerns in patients with diabetic macular edema (DME

article thumbnail

Abzena, Alira Health and Oncodesign launch DRIVE Biologics to support access to specialist services from discovery to clinical development for oncology and inflammation

Pharma Mirror

This joint service offering, DRIVE™-Biologics, will leverage Abzena’s strength in design and developability, and cell line development through to commercial manufacturing.

article thumbnail

Can machine learning accelerate drug formulation?

Outsourcing Pharma

Clinical DevelopmentResearch emerging from the University of Toronto found that using machine learning models was able to guide the design of long-acting drug formulations.

Research 104
article thumbnail

Preclinical program with potential for disease modifying therapeutic

Outsourcing Pharma

A license agreement from UCB to Pheno Therapeutics will enable the acceleration of a promising new drug tackling neurological diseases towards clinical development. Clinical Development

article thumbnail

Spalding Clinical and FDA research dangers of drug-opioid combinations

Outsourcing Pharma

The clinical trial was set up to investigate whether combining opioids with common psychotropic drugs would increase risk of respiratory depression. Clinical Development

article thumbnail

Novavax Announces COVID-19 Vaccine Clinical Development Progress

The Pharma Data

Nasdaq: NVAX), a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, today provided an update on its COVID-19 vaccine program. Novavax completed enrollment of 15,000 participants in a pivotal Phase 3 clinical trial being conducted in the U.K.

article thumbnail

Apex gets approval for ‘world’s largest’ take home psychedelic trial

Outsourcing Pharma

Clinical DevelopmentThe company plans to conduct a Phase 2b trial to test its APEX-52 psilocybin drug candidate to treat adults with post-traumatic stress disorder.

Drugs 82
article thumbnail

Phesi: Long-term damage from COVID-19 movement restrictions on clinical development is becoming clearer

BioPharma Reporter

Phesi led analysis reveals an overall decrease in the number of recruiting trials and higher proportion of Phase 2 terminations in 2022. Markets & Regulations

Trials 52
article thumbnail

AlgoTherapeutix Receives Regulatory Approval to Initiate Clinical Development of ATX01

The Pharma Data

AlgoTherapeutix recently raised a 12M€ Series A that will fund the Phase 1 and 2 clinical development of ATX01. Their lead programme ATX01 is in clinical development in Chemotherapy-Induced Peripheral Neuropathy. 15, 2020 07:15 UTC.

article thumbnail

Brii Biosciences Provides Update on Strategic Clinical Development Progress

BioTech 365

Brii Biosciences Provides Update on Strategic Clinical Development Progress Brii Biosciences Provides Update on Strategic Clinical Development Progress Company received U.S.

article thumbnail

Eckert & Ziegler Affiliate Receives Further NIAID Funding for Clinical Development

BioTech 365

DGAP-News: Eckert & Ziegler Strahlen- und Medizintechnik AG / Key word(s): Contract Eckert & Ziegler Affiliate Receives Further NIAID Funding for Clinical Development 21.07.2022 / 09:00 The issuer is solely responsible for the content of this announcement.

article thumbnail

Aqemia raises €30m to scale drug discovery platform

Outsourcing Pharma

Clinical DevelopmentThe company states that its platform combines quantum-inspired physics and machine learning to accelerate drug discovery.

article thumbnail

Gilead provides $7.6m in grants for health equity in breast cancer

Outsourcing Pharma

Clinical DevelopmentThe pharma company provides funding to 24 community organizations throughout the US, as part of its newly created âToward Health Equity Oncology Grantâ.

article thumbnail

Aardex and Cambridge Cognition cooperate on decentralized trials

Outsourcing Pharma

Aardex will provide adherence monitoring tools to Cambridge Cognition for use in hybrid and fully decentralized clinical trial services. Clinical Development

article thumbnail

Biophytis provides updates on Sarconeos (BIO101) clinical development

BioTech 365

Biophytis / Key word(s): Miscellaneous Biophytis provides updates on Sarconeos (BIO101) clinical development 07-Apr-2022 / 08:00 CET/CEST Biophytis provides updates on Sarconeos (BIO101)clinical development Sarcopenia (SARA) : discussions engaged with FDA for the preparation of a Phase 2-3 program … Continue reading → EQS Newsfeed

article thumbnail

Metacrine Updates IBD Clinical Development Strategy and Implements Restructuring Plan

BioTech 365

Metacrine Updates IBD Clinical Development Strategy and Implements Restructuring Plan Metacrine Updates IBD Clinical Development Strategy and Implements Restructuring Plan U.S. FDA clears IND to evaluate MET642 for the treatment of ulcerative colitis Sufficient capital to complete Phase 2 IBD … Continue reading → GlobeNewswire

article thumbnail

The Case for Early Regulatory Consideration for Clinical Development of Chimeric Antigen Receptor T cell (CART)

CATO Research

Hence, the next clinical milestone will very likely be the development of allogeneic CART therapies that could offer off-the-shelf products with immediate availability as an on-demand therapeutic option for patients with high unmet medical needs. Meeting Clinical Objectives.

article thumbnail

CANbridge Pharmaceuticals Appoints Pauline Li as Senior Vice President of Clinical Development and Operations

BioTech 365

CANbridge Pharmaceuticals Appoints Pauline Li as Senior Vice President of Clinical Development and Operations CANbridge Pharmaceuticals Appoints Pauline Li as Senior Vice President of Clinical Development and Operations BEIJING & CAMBRIDGE, Mass.–(BUSINESS

article thumbnail

AstraZeneca automates DNA synthesis to slash costs and timelines

Outsourcing Pharma

Clinical DevelopmentAstraZeneca has cut the cost and time needed to complete DNA synthesis by integrating an assembly framework into Benchling.

DNA 52
article thumbnail

AlgoTherapeutix Receives Regulatory Approval to Initiate Clinical Development of ATX01

BioTech 365

article thumbnail

Charles River wins gene therapy manufacturing contract from Nanoscope

Outsourcing Pharma

Clinical DevelopmentCharles River Laboratoriesâ growing gene therapy manufacturing capabilities have landed it a deal with the eye disease biotech Nanoscope Therapeutics.

article thumbnail

ESCAPE Bio Snags $73 Million to Advance Neurodegenerative Clinical Development Programs

BioSpace

Clinical-stage biopharmaceutical firm ESCAPE Bio has snagged a $73 million crossover financing deal, led by Wellington Management Company, which will help advance the company’s two clinical development programs of precision neurology medicines for patients with genetic neurodegeneration

article thumbnail

Novartis Provides Update on AVXS-101 Intrathecal Clinical Development Program

The Pharma Data

Trial design and other details are being evaluated and a comprehensive update on the overall Novartis SMA clinical development program will be provided at a future time following further discussions with health authorities.

article thumbnail

Vertex Advances VX-147 Into Pivotal Clinical Development for People With APOL1-Mediated Kidney Disease

BioTech 365

Vertex Advances VX-147 Into Pivotal Clinical Development for People With APOL1-Mediated Kidney Disease Vertex Advances VX-147 Into Pivotal Clinical Development for People With APOL1-Mediated Kidney Disease – Single pivotal trial to initiate later this month targets the broad patient population … Continue reading → Business Wire

Trials 52
article thumbnail

J&J’s ketamine nasal spray outperforms traditional depression treatment

Outsourcing Pharma

Clinical DevelopmentA study pitted Spravato against quetiapine extended-release, with the results showing that J&Jâs product was more effective in patients with treatment-resistant major depressive disorder.

article thumbnail

Vaxxas raises $23m for needle-free vaccine clinical development and manufacturing

BioPharma Reporter

Vaxxas has completed a financing round which raised US$23m (A$34m) in new funds: allowing the company to progress multiple vaccine programs in the clinic and ramp up manufacturing capabilities towards commercial scale. Bio Developments

article thumbnail

Innovaderm Shines as Key Partner in Clinical Development and Study Management of Newly FDA-Approved Psoriasis Drug, Tapinarof

BioTech 365

article thumbnail

Human element important for decentralized trial advancement

Outsourcing Pharma

Clinical DevelopmentDuring the Decentralized Trial Technology event, experts from CVS Health, University of Chicago, and ACRP shared insight on what can increase DCT success.

Trials 104
article thumbnail

ZS Launches ZAIDYN™ Clinical Development, Expanding Its Digital Life Sciences Platform

BioTech 365

ZS Launches ZAIDYN™ Clinical Development, Expanding Its Digital Life Sciences Platform ZS Launches ZAIDYN™ Clinical Development, Expanding Its Digital Life Sciences Platform ZAIDYN Clinical Development empowers life sciences companies to break down silos in clinical trial design and planning, remove … Continue reading → Business Wire

article thumbnail

Taysha Gene Therapies Announces Initiation of Clinical Development of TSHA-118 for the Treatment of CLN1 Disease

BioTech 365

Taysha Gene Therapies Announces Initiation of Clinical Development of TSHA-118 for the Treatment of CLN1 Disease Taysha Gene Therapies Announces Initiation of Clinical Development of TSHA-118 for the Treatment of CLN1 Disease CTA approved by Health Canada in November 2021; … Continue reading → Business Wire

article thumbnail

 Domain Therapeutics Receives a Single Digit Multimillion Development Milestone Payment from Merck for M1069 Clinical Development in Immuno-Oncology

BioTech 365

article thumbnail

Osivax Secures EUR 10M Grant from Bpifrance to Support Clinical Development of OVX836, a Broad-Spectrum Influenza Vaccine

BioTech 365

article thumbnail

Medable launches new tool for global remote consent

Outsourcing Pharma

Clinical DevelopmentThe company announces that Total Consent, an SaaS electronic management solution, is now available across more than 120 different locations globally.

article thumbnail

Clario releases 20 years of data working on decentralized trials

Outsourcing Pharma

Clinical DevelopmentThe company reveals some of its data on the number of trials and patients that have been supported through its tools.

Trials 83